DEFA14A: Silo Pharma Postpones Annual Stockholders Meeting to December 20, 2024

Silo Pharma has rescheduled its 2024 annual meeting of stockholders from November 12, 2024, to December 20, 2024, and established a new record date.

Summary

• Silo Pharma has postponed its 2024 annual meeting of stockholders, originally scheduled for November 12, 2024.
• The meeting has been rescheduled to December 20, 2024.
• A new record date of November 12, 2024, has been set for stockholders eligible to attend and vote.
• Stockholders will receive a new notice of the Annual Meeting and will need to resubmit their votes, even if they have previously voted.
• The company has filed a proxy statement with the SEC regarding the business to be conducted at the Annual Meeting.
• The company's directors and executive officers may be deemed to be participants in the solicitation of proxies from the company's stockholders.
• The document contains forward-looking statements that are subject to risks and uncertainties.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the announcement is a procedural update regarding the rescheduling of the annual meeting.

Risks

• The document contains forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially.
• These risks include changes to anticipated sources of revenues, future economic and competitive conditions, difficulties in developing the Company's technology platforms, retaining and expanding the Company's customer base, and fluctuations in consumer spending on the Company's products.

Future Outlook

The Company disclaims any obligations to publicly update or release any revisions to the forward-looking information contained in this presentation, whether as a result of new information, future events, or otherwise, after the date of this presentation or to reflect the occurrence of unanticipated events except as required by law.

Industry Context

This announcement is a routine update regarding the company's corporate governance and shareholder engagement. It does not provide specific insights into the company's performance relative to its peers in the pharmaceutical industry.

Stakeholder Impact

• Shareholders need to be aware of the change in date for the annual meeting and resubmit their votes.

Next Steps

• The Company will deliver a new notice of the Annual Meeting to stockholders as of the new record date.
• Stockholders will need to resubmit their votes.

Key Dates

Keywords

Annual Meeting, Stockholders, Proxy Statement, Rescheduled, Silo Pharma, Voting